AORT vs FCX · rev $242.1M vs P/E 38, rev $13.26B
Artivion Inc (AORT) versus Freeport-McMoran Copper & Gold Inc (FCX) — a side-by-side from cached financials, not a winner call.
Artivion Inc (AORT) is a medical devices company listed on US.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Latest reported AORT revenue for 2026-06-30 was $242.1M. Net income was -$12.1M. AORT currently screens at market cap $1.45B.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
AORT currently screens at market cap $1.45B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Not investment advice. Open the AORT and FCX stock pages for the full models.
Not investment advice.